兴齐眼药
(300573)
| 流通市值：99.42亿 | | | 总市值：129.72亿 |
| 流通股本：2.72亿 | | | 总股本：3.55亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,400,873,956.41 | 683,337,441.58 | 2,472,852,236.79 | 1,903,728,804.18 |
| 营业总成本 | 921,296,880.83 | 456,989,442.88 | 1,667,470,697.01 | 1,215,800,734.13 |
| 其他经营收益 | | | | |
| 营业利润 | 495,015,152.24 | 232,577,701.6 | 822,222,229.31 | 703,467,820.91 |
| 利润总额 | 482,298,715.46 | 230,119,426.69 | 800,275,673.72 | 688,770,872.55 |
| 净利润 | 430,404,293.36 | 206,414,274.49 | 695,855,596.25 | 598,906,386.15 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | 1,416,666.67 | - |
| 综合收益总额 | 430,404,293.36 | 206,414,274.49 | 697,272,262.92 | 598,906,386.15 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,014,206,648.5 | 1,132,738,018.18 | 930,732,444.32 | 944,694,296.32 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,729,079,064.95 | 1,616,181,869.2 | 1,608,245,264.41 | 1,474,777,610.01 |
| 资产总计 | 2,743,285,713.45 | 2,748,919,887.38 | 2,538,977,708.73 | 2,419,471,906.33 |
| 流动负债: | | | | |
| 流动负债合计 | 519,037,043.81 | 506,954,378.26 | 500,828,711.55 | 498,325,822.54 |
| 非流动负债: | | | | |
| 非流动负债合计 | 61,211,011.81 | 56,860,813.57 | 60,101,928.1 | 63,853,511.47 |
| 负债合计 | 580,248,055.62 | 563,815,191.83 | 560,930,639.65 | 562,179,334.01 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,163,037,657.83 | 2,185,104,695.55 | 1,978,047,069.08 | 1,857,292,572.32 |
| 股东权益合计 | 2,163,037,657.83 | 2,185,104,695.55 | 1,978,047,069.08 | 1,857,292,572.32 |
| 负债和股东权益合计 | 2,743,285,713.45 | 2,748,919,887.38 | 2,538,977,708.73 | 2,419,471,906.33 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,402,417,586.33 | 679,067,444.5 | 2,457,587,752.47 | 1,848,135,635.78 |
| 经营活动现金流出小计 | 1,008,970,972.83 | 470,620,045.06 | 1,704,198,966.79 | 1,273,615,451.48 |
| 经营活动产生的现金流量净额 | 393,446,613.5 | 208,447,399.44 | 753,388,785.68 | 574,520,184.3 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | -620,947.49 | - | 4,681,632.36 | 44,247.79 |
| 投资活动现金流出小计 | 61,999,343.6 | 27,037,575.12 | 274,417,530.99 | 131,875,957.56 |
| 投资活动产生的现金流量净额 | -62,620,291.09 | -27,037,575.12 | -269,735,898.63 | -131,831,709.77 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 60,500,000 | - | 237,521,731.49 | 209,763,009.81 |
| 筹资活动现金流出小计 | 320,494,804.47 | 1,999,636.26 | 695,912,830.95 | 641,413,011.06 |
| 筹资活动产生的现金流量净额 | -259,994,804.47 | -1,999,636.26 | -458,391,099.46 | -431,650,001.25 |
| 汇率变动对现金及现金等价物的影响 | 1,702,119.61 | 907,818.63 | -1,669,055.28 | -1,647,447.59 |
| 现金及现金等价物净增加额 | 72,533,637.55 | 180,318,006.69 | 23,592,732.31 | 9,391,025.69 |
| 期末现金及现金等价物余额 | 458,963,552.82 | 566,747,921.96 | 386,429,915.27 | 372,228,208.65 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 72,533,637.55 | - | 23,592,732.31 | - |
最新报告期：2026-09-08| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 国投证券 | 冯俊曦 | 2.65 | 3.57 | 4.66 | 2026-09-08 |
| 开源证券 | 余汝意 | 2.75 | 3.70 | 5.04 | 2026-08-29 |